Scale-up, efficiency, available markets: The Digest’s 2017 Multi-Slide Guide to BioAmber

BioAmber reported an unsurprisingly lackluster sales figure and a Q1 loss of $10.5M compared to a loss of $8.1M for Q1 2016 – unsurprising given the delays at major customer PTT. We covered the fortunatelys and unfortunatelys of this intriguing storyline here.

But even better, EVP Mike Hartmann gave this illuminating overview of the technology, markets and prospects on Planet BioAmber, in these slides below.